560 related articles for article (PubMed ID: 29515580)
1. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.
Poggi A; Varesano S; Zocchi MR
Front Immunol; 2018; 9():262. PubMed ID: 29515580
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.
Poggi A; Musso A; Dapino I; Zocchi MR
Immunol Lett; 2014; 159(1-2):55-72. PubMed ID: 24657523
[TBL] [Abstract][Full Text] [Related]
3. Effect of mesenchymal stem cells-derived exosomes on tumor microenvironment: Tumor progression versus tumor suppression.
Shojaei S; Hashemi SM; Ghanbarian H; Salehi M; Mohammadi-Yeganeh S
J Cell Physiol; 2019 Apr; 234(4):3394-3409. PubMed ID: 30362503
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.
Poggi A; Giuliani M
Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27834810
[TBL] [Abstract][Full Text] [Related]
6. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
Whiteside TL
Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cells in the Tumor Microenvironment.
Atiya H; Frisbie L; Pressimone C; Coffman L
Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
[TBL] [Abstract][Full Text] [Related]
9. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
[TBL] [Abstract][Full Text] [Related]
10. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
Chauhan A; Agarwal S; Masih M; Gautam PK
Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.
Hazrati A; Malekpour K; Mirsanei Z; Khosrojerdi A; Rahmani-Kukia N; Heidari N; Abbasi A; Soudi S
Front Immunol; 2023; 14():1280601. PubMed ID: 38022534
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Mediators in Glioma Microenvironment Play a Dual Role in Gliomagenesis and Mesenchymal Stem Cell Homing: Implication for Cellular Therapy.
Al-Kharboosh R; ReFaey K; Lara-Velazquez M; Grewal SS; Imitola J; Quiñones-Hinojosa A
Mayo Clin Proc Innov Qual Outcomes; 2020 Aug; 4(4):443-459. PubMed ID: 32793872
[TBL] [Abstract][Full Text] [Related]
13. Similarities between Tumour Immune Response and Chronic Wound Microenvironment: Influence of Mesenchymal Stromal/Stem Cells.
Peta KT; Ambele MA; Pepper MS
J Immunol Res; 2021; 2021():6649314. PubMed ID: 33860061
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
Razmkhah M; Abtahi S; Ghaderi A
Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment.
Kidd S; Caldwell L; Dietrich M; Samudio I; Spaeth EL; Watson K; Shi Y; Abbruzzese J; Konopleva M; Andreeff M; Marini FC
Cytotherapy; 2010 Sep; 12(5):615-25. PubMed ID: 20230221
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment.
François S; Usunier B; Forgue-Lafitte ME; L'Homme B; Benderitter M; Douay L; Gorin NC; Larsen AK; Chapel A
Stem Cells Transl Med; 2019 Mar; 8(3):285-300. PubMed ID: 30451398
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression.
Wang M; Chen B; Sun XX; Zhao XD; Zhao YY; Sun L; Xu CG; Shen B; Su ZL; Xu WR; Zhu W
Exp Cell Res; 2017 Dec; 361(1):19-29. PubMed ID: 28964780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
